Dentists in Osage City, KS Accepting Medicare
2 Dentists found. Showing 1 - 2
 Dr. Robert H Harmon, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 840 Lakin Street, Osage City, KS 66523 Phone: 785-528-3773 Fax: 785-528-3504 |
Dr. Matthew R Harmon, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 840 Lakin Street, Osage City, KS 66523 Phone: 785-528-3773 |
News Archive
Smoking in cars - won't somebody please think of the children!
Australian Medical Association Victoria (AMA) President Dr Mark Yates has praised the support from various health lobby groups and Democrats Leader Senator Lyn Allison to ban smoking in cars carrying passengers, and in particular children.
Hamsters and ferrets clear low dose SARS-CoV-2 infection in 14 days
A recent study by French researchers has demonstrated that experimental exposure to severe acute respiratory coronavirus 2 (SARS-CoV-2) is capable of inducing mild infection in hamsters and ferrets within 7 – 10 days of exposure. However, the infection completely resolves within 14 days. The study is currently available on the bioRxiv preprint server.
Wistar Institute study shows that PI3K inhibitors may make a patient's cancer even worse
The enzyme phosphatidylinositol-3 kinase (PI3K) appears to be exploited in almost every type of human cancer, making it the focus of considerable interest as a therapeutic target, with many PI3K-inhibiting drugs currently in various stages of clinical development. However, PI3K inhibitors have only shown modest clinical activity with patients who receive these drugs experiencing very little improvement in survival.
Palatin begins bremelanotide phase 3 study for treatment of female sexual dysfunction
Palatin Technologies, Inc., a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical needs and commercial potential, today announced that it has started its bremelanotide pivotal registration program.
Auxilium Pharmaceuticals raises $115.7 million for general corporate purposes
Auxilium Pharmaceuticals, Inc. announced today that it has closed its previously announced public offering of 3,000,000 shares of its common stock at a price of $34.50 per share.
› Verified 7 days ago